Pituitary gonadotropin responsiveness with danazol

Area of Science:

• Endocrinology
• Reproductive Biology
• Pharmacology

Background:

• Danazol is a synthetic steroid with antiestrogenic and antiandrogenic properties.
• Previous studies indicated danazol's ability to lower serum luteinizing hormone (LH) levels.

Purpose of the Study:

• To investigate the mechanism by which danazol affects serum LH levels.
• To determine if danazol's effect on LH is mediated centrally (hypothalamus) or peripherally (pituitary).

Main Methods:

• Castrated female rats were administered danazol daily for 4 days.
• Serum LH levels were measured after danazol administration.
• Response to exogenous LH-releasing hormone (LHRH) was assessed in danazol-treated and control rats.

Main Results:

• Danazol administration resulted in a dose-dependent decrease in serum LH levels.
• Rats treated with a sufficient dose of danazol to lower LH still showed a normal LH increase in response to administered LHRH.
• The LH response to LHRH was comparable between danazol-treated and control animals.

Conclusions:

• The findings suggest that danazol primarily inhibits the secretion of hypothalamic LHRH.
• Danazol's action on lowering serum LH is likely mediated at the hypothalamic level.
• While a direct pituitary effect cannot be entirely excluded, the data strongly support a central inhibitory mechanism for danazol on LH secretion.